Skip to content Skip to footer

Loading Results

China human genetic regulatory regime update

August 2022

Following the entering into effect of the Biosecurity Law, Data Security Law and Rules on Human Genetic Resources Administration, China is poised to issue the Implementation Regulation to Rules on Human Genetic Resources Administration (“Implementation Regulation”) which will provide detailed requirements in relation to the collection, storage, use and outbound transfer from China of human genetic materials such as blood samples as well as the related data. The consultation paper of the Implementation Regulation allows companies to get prepared for when the Implementation Regulation is officially adopted. 

This paper highlights the detailed requirements set out in the consultation paper which are expected to be officially adopted soon.

Contact us

Jia Xu

Pharma and Healthcare Industry Leader, PwC China

Tel: +[86] (10) 6533 7734

Bill Yuan

Partner, PwC China

Tel: +[86] (21) 2323 2747

Calvin Zhang

Partner, PwC China

Tel: +[86] (20) 3819 2187

Follow us